Tag:
ARC16
Latest Headlines
Latest Headlines
Astellas hands back rights to NeuroSearch program
Japan's Astellas won't be developing an experimental new drug for schizophrenia it in-licensed from Denmark's NeuroSearch. The Danish company says that Astellas has returned the global rights to
